Fuji Pharma: High Scope For Growth In U.S. Foray, Biosimilars, And Women's Health DrugsSeeking Alpha • 05/08/23
Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]PRNewsWire • 05/08/23
VTRS INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Viatris Inc.PRNewsWire • 04/28/23
Viatris and Mapi Pharma to Highlight Latest Results of Multiple Sclerosis Research at American Academy of Neurology 75th Annual MeetingPRNewsWire • 04/24/23